title: Evaluation of commercially available serologic diagnostic tests for chikungunya virus.
abstract: Chikungunya virus (CHIKV) is present or emerging in dengue virus-endemic areas. Infections caused by these viruses share some common signs/symptoms, but prognosis, patient care, and persistent symptoms differ. Thus, accurate diagnostic methods are essential for differentiating the infections. We evaluated 4 CHIKV serologic diagnostic tests, 2 of which showed poor sensitivity and specificity.
authors.forename: Christine M
authors.initials: CM
authors.lastname: Prat
authors.forename: Olivier
authors.initials: O
authors.lastname: Flusin
authors.forename: Amanda
authors.initials: A
authors.lastname: Panella
authors.forename: Bernard
authors.initials: B
authors.lastname: Tenebray
authors.forename: Robert
authors.initials: R
authors.lastname: Lanciotti
authors.forename: Isabelle
authors.initials: I
authors.lastname: Leparc-Goffart
mesh_terms: D065632:Chikungunya Fever / Q000175:diagnosis*; D002646:Chikungunya virus / Q000145:classification*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods / Q000592:standards; D006801:Humans; D011933:Reagent Kits, Diagnostic / Q000592:standards; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D012698:Serologic Tests / Q000379:methods* / Q000592:standards
chemical_list: D011933:Reagent Kits, Diagnostic